No effective drug treatments are available for coronavirus disease 2019 (COVID-19). Host-directed
therapies targeting the underlying aberrant immune responses leading to pulmonary …

BACKGROUND. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
coronavirus 2 (SARS-CoV-2), has become a pandemic. This study addresses the clinical …

Background SARS-CoV-2-caused coronavirus disease (COVID-19) is posing a large
casualty. The features of COVID-19 patients with and without pneumonia, SARS-CoV-2 …

In coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, the relationship between disease severity and the host …

The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented threat to
global public health. Herein, we utilized a combination of targeted and untargeted tandem …

COVID-19 is associated with 5.1% mortality. Although the virological, epidemiological, clinical,
and management outcome features of COVID-19 patients have been defined rapidly, the …

To describe the epidemiological and clinical characteristics of patients with Corona Virus
Disease 2019 (COVID-19) in Beijing. To analyze the application of corticosteroids in patients …

Granulocyte colony-stimulating factor (GM-CSF), produced by CD4 + T cells, has recently
been implicated in the pathogenesis of inflammatory diseases, such as multiple sclerosis and …

This study aimed to analyze the clinical characteristics and potential predictors of disease
severity in patients with coronavirus disease 2019 (COVID-19). We retrospectively analyzed …

HIV subtypes convey important epidemiological information and possibly influence the rate
of disease progression. In this study, HIV disease progression in patients infected with …